|
August 1, 2007. The CFAR has leased an apartment to facilitate housing visiting scholars. To find out more click here.
June 21, 2007. Drs. Whalen and Sethi receive 2 of 10 Doris Duke Foundation Awards to continue their AIDS-related research. To find out more, click here.
June 4, 2007. The 2007-08 Case/UHC CFAR Development Awards have been awarded. To find out more click here.
Article: Predictive Value of Plasma HIV RNA Level on Rate of CD4 T-Cell Decline in Untreated HIV Infection, Rodriguez B, et. al. Journal of the American Medical Association, 27 September 2006. Click here for press release on article.
Announcement of Award. Case Chemist, Dr. Mary Barkley, takes on HIV-1 virus with $1 million support from NIH. September 15, 2006. Click here for article on award.
Article: Microbicide Project: Prevention of Vaginal SHIV Transmission in Rhesus Macaques Through Inhibition of CCR5, Lederman, et.al., Science, 15 October 2004, click here.
The Case Western Reserve University/University Hospitals Center For AIDS Research (Case CFAR) has been continually funded since its initiation in April 1994 as one of 11 such centers of excellence established by the National Institutes of Health. The CFAR has a mandate to coordinate basic and clinical research activities and to promote interdisciplinary research in HIV infection and AIDS. Comprising more than 140 faculty researchers at the Schools of Medicine, Nursing, Arts and Sciences, and Law, the CFAR provides core resources, seminars, lectureships, publications and developmental funding to promote and strengthen the AIDS resarch programs at the University and its affiliated institutions. CFAR membership includes scientist and clinicians from Case, University Hospitals of Cleveland, MetroHealth Medical Center, The Cleveland Veterans Administration Center and the Cleveland Clinic Foundation. Current key areas of research strength include a) international aspects of AIDS; b) AIDS clinical research; c) HIV immunology; d) molecular virology; e) mycobacterial disease; f) AIDS-related malignancies; and g) HIV prevention. |
|
|
Center
for AIDS Research Grant Renewed With $8
Million Award from NIH CLEVELAND
-- The Case Western Reserve University/University
Hospitals of Cleveland Center for AIDS Research
(Case CFAR) announced that it has received a
five-year grant from the National Institutes of
Health, providing a 39 percent increase in funding
over the CFAR’s previous award from the NIH.
The NIH award provides $8 million for CFAR
operations. Additionally,
the NIH support provides the center with the
opportunity to apply for supplemental funding each
year for various AIDS-related projects. Michael
M. Lederman, M.D., director of the Case CFAR,
responded to the receipt of the grant: “This renewal of our Center for AIDS Research is wonderful news. It
represents recognition by the NIH of the strong AIDS
research program at Case and UHC, and the hard work
of the more than 130 AIDS researchers who comprise
this center of excellence.
This five-year award will provide our
researchers here and in Africa access to resources
and facilities to speed the progress of their
work.” The Case CFAR provides clinical and technological support to researchers working on AIDS-related projects at Case, UHC, MetroHealth Medical Center, the Cleveland Clinic Foundation, and several international sites. It is part of a program that was established by the NIH to promote collaboration between basic and clinical researchers on AIDS-related projects, emphasizing translational research in which findings from the laboratory are brought to the clinic and vice versa. There are 21 such centers currently funded by the NIH. The Case CFAR is the only one located in the Midwest. “One
of the positive benefits of the CFAR is the uniting
of basic scientists working on AIDS with their
clinical colleagues,” said Jonathan Karn, Ph.D.,
associate director of the CFAR. “With the Case
School of Medicine rapidly expanding centers of
excellence, such as the CFAR, Case will continue to
become more attractive to the outstanding
researchers we are actively recruiting.”
Since
its founding in 1994, the Case CFAR has been
dedicated to coordinating an ever-expanding spectrum
of AIDS-related activities.
Major strengths of the Case CFAR include
clinical and translational research, international
research, and in training young researchers, both on
a national and international level.
In Cleveland, a close, dynamic relationship
between the CFAR and the NIH-funded AIDS Clinical
Trials Unit (a collaboration between UHC,
MetroHealth, and the Cleveland Clinic), assists in
fulfilling these institutions’ mandates as centers
of excellence and providers of the highest quality
patient care. On
the international front, a long-standing scientific
relationship with Makerere University in Kampala,
Uganda, has culminated in establishing sophisticated
CFAR laboratories in Uganda, providing support for
AIDS-related research in Africa. The Case CFAR works actively with other Case centers and departments in areas of mutual interest. In addition to the AIDS Clinical Trials Unit, these include the Comprehensive Cancer Center (AIDS–related malignancies, studies of immune restoration), the Tuberculosis Research Unit (TBRU, HIV/TB interactions), the Skin Diseases Research Center’s Center for Medical Mycology (CMM-opportunistic fungal infections), the Center for Global Health and Disease (international research), the EpID Center (epidemiology/biostatistics, international research), and the Department of Biomedical Ethics and the Law-Medicine Center (Ethics of AIDS Research and Care Research Program).
CITATION
OF THE CASE/UHC CENTER FOR AIDS RESEARCH are strongly encouraged to cite the CFAR in all publications resulting
from the use of the services.
NIH
Grant Number: AI36219 Electronic
copies of the Case/UHC CFAR logo can be obtained by
contacting Bob Bucklew at rob2@case.edu
or 216.844.2247; or
Mary
Robertson at robertson.mary@clevelandactu.org
or 216.844.2342
|
